Rumeyza Kazancioglu TürkiyeBezmialem Vakif University

She graduated from Istanbul University, Istanbul Faculty of Medicine in 1991, and completed her Internal Medicine Residency and Nephrology fellowship at the same faculty until 2001. She is a former ISN fellow, currently working at Bezmialem Vakif University School of Medicine Division Nephrology. Prof. Kazancıoğlu has published many national and international articles, books and book chapters. Her main interests are in PD, disaster nephrology, CKD and ESKD.

Institution

Day 1 - Sunday April 14, 2024

Time	Session

9 a.m. 10:30 a.m.	Hands on Big Data Mining for the Nephrologist in 2024 SK1001 ChairpersonHeather Ascani United StatesUniversity of Michigan ChairpersonKatherine Tuttle United StatesUniversity of Washington School of Medicine, Division of Nephrology ChairpersonMatthias Kretzler United StatesUniversity of Michigan Looking for Data on Glomerular Diseases: How to Find the Treasures You Are Looking for With a Click of a Mouse SpeakerViji Nair United StatesUniversity of Michigan Open Science in an Open Community: Resources of the Kidney Precision Medicine Project for CKD and AKI SpeakerMatthias Kretzler United StatesUniversity of Michigan The Future is Now: How to Mine Cells and Neighborhoods of the Kidney in Health and Disease SpeakerJulio Saez-Rodriguez julio.saez@uni-heidelberg.deGermanyHeidelberg University Panel Discussion Hall C1
11 a.m. 12 p.m.	Plenary Session 2: CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? (Obiageli Eunice Nnodu, Nigeria) PL2 ChairpersonAgnes Fogo United States ChairpersonGuillermo Rosa Diez guillermo.rosadiez@hospitalitaliano.org.arArgentinaHospital Italiano de Buenos Aires; Argentinean Society of Nephrology; Latinoamerican Society of Nephrology and Hypertension; International Society of Nephrology My Story SpeakerVictoria Gray vwright_03@yahoo.comUnited States CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? Hugh de Wardener Lecture SpeakerObiageli Eunice Nnodu oennodu@gmail.comNigeriaUniversity of Abuja Hall A
12:15 p.m. 1:15 p.m.	Transplant Tourism in My Clinic: What Should I Do? ISN-DICG Joint Session CHAL1001 ChairpersonDomingo Casadei drdomingocasadei@gmail.com ChairpersonVivekanand Jha IndiaGeorge Institute for Global Health India How to Achieve Transparent and Regulated Organ Donation and Transplantation SpeakerMaria Amalia Matamoros Costa RicaCaja Costarricense del Seguro social Non-resident Foreigners in Argentina: Legal Framework to Prevent Transplant Tourism SpeakerLiliana Bisigniano lbisigniano@incucai.gov.arArgentinaLiliana Bisigniano MD How to Handle Cases of Presumed Transplant Tourism SpeakerKen Sakai kensakai@med.toho-u.ac.jpJapanDepartment of Nephrology, Toho University Omori Medical Center Q and A Hall C1
4:30 p.m. 5:30 p.m.	New Developments in CKD Epidemiology Research IK1001 ChairpersonMaarten Taal United KingdomUniversity of Nottingham ChairpersonRoberto Pecoits Filho United StatesArbor Research Collaborative for Health Big Data Lab LAB-01 Patient-reported Outcome Measures: How Do Patients Experience CKD? SpeakerAdeera Levin CanadaUniversity of British Columbia and Providence Health Care Trial Simulation Using Observational Data SpeakerAngelo Karaboyas angelo.karaboyas@arborresearch.orgUnited StatesArbor Research Collaborative for Health Using Routinely Collected Big Datasets for Clinical Research in CKD: Opportunities and Challenges SpeakerDorothea Nitsch United KingdomLondon School of Hygiene & Tropical Medicine Q and A Hall C4

Day 2 - Monday April 15, 2024

Time	Session

9 a.m. 10:30 a.m.	Hot Digests of Kidney Inflammation and Immunity: ISN-JSN Joint Session LF2002 ChairpersonAlejandra Quevedo Smuclir alejandra.s.quevedo@gmail.comArgentinaSAN ChairpersonCarmen Tzanno Branco Martins BrazilSLANH, ISN ChairpersonSaori Nishio saorin@med.hokudai.ac.jpJapan Update of Glomerulonephritis SpeakerFernando Fervenza fervenza.fernando@mayo.eduUnited StatesMayo Clinic Inflammation and Metabolic Kidney Disease SpeakerJun Wada junwada@okayama-u.ac.jpJapanOkayama University A Novel Treatment Targeting Kidney Inflammation SpeakerMaria Jose Soler SpainHospital del Vall d´Hebron Controlling Kidney Inflammation Through the Nervous System SpeakerShinji Tanaka shitanaka@m.u-tokyo.ac.jpJapanDivision of Nephrology and Endocrinology, the University of Tokyo Hospital Q and A Hall C3
10:30 a.m. 11 a.m.	Nephrology in Jeopardy: A Sustainable Kidney Care Quiz SPOT-12 Spotlight ChairpersonBrendan Smyth brendan.smyth@sydney.edu.auAustralia Spotlight ChairpersonLetizia De Chiara letizia.dechiara@unifi.itItalyDepartment of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence Spotlight ChairpersonUgochi Onu Nigeria Spotlight Stage 1 (exhibition hall)
11 a.m. 12 p.m.	Plenary Session 3: Generative AI Revolution in Medicine (Michal Rosen-Zvi, Israel) PL3 ChairpersonJose Vicente Sanchez Polo visanpolo@gmail.comGuatemalaRenal Division Social Security Institute. Nephrology Residence Program Coordinator, San Carlos University School of Medicine. Latin-American Society Of Nephrology (SLANH) ChairpersonMeg Jardine AustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia Generative AI Revolution in Medicine SpeakerMichal Rosen-Zvi ROSEN@il.ibm.comIsraelhttps://research.ibm.com/ Acceptance Speech by Awardee (Schrier Award), with Tasnuva Sarah Kashem (UK) and Farnaz Nobi (Bangladesh) SpeakerMohammad Shakib Uz Zaman Arefin shakib04@yahoo.comBangladesh Hall A
12:15 p.m. 1:15 p.m.	Natural and Man-made Disasters and Kidney Care. ISN-ERA Special Lecture BKH03 ChairpersonIfeoma Ulasi NigeriaCollege of Medicine, University of Nigeria ChairpersonVictor Frajewicki vfraje@clalit.org.ilIsraelDepartment of Nephrology and Hypertension, Carmel Medical Center, Haifa The Next Pandemic - What Has the Nephrology Community Learned From COVID-19? SpeakerRaul Lombardi lombardi.raul2@gmail.comUruguayDepartment of Nephrology, Schoole of Medicine, Uni Challenges in Nephrological Care During Difficult Situations: Lessons From Venezuela SpeakerLorendiz Pamela Ronca Chacare lorendiz.ronca@gmail.comVenezuelaSociedad Venezolana de Nefrología Kidney Care During Earthquakes: Lessons Learned From Turkey SpeakerRumeyza Kazancioglu drkazancioglu@yahoo.comTürkiyeBezmialem Vakif University Provision of Renal Care During Man-made Disasters and Armed Conflicts: A Challenging Proposition SpeakerRobert Najem robertnajem@yahoo.frLebanonLebanese University, Faculty of Medical Sciences. Q and A Hall D
3 p.m. 4 p.m.	Transplant-Onconephrology CHAL04 ChairpersonDario Roccatello dario.roccatello@unito.itItaly ChairpersonGayatri Nair gnair1@northwell.eduUnited StatesNorthwell Health, NY ChairpersonMariano Arriola marianoarriola@hotmail.comArgentinaSAT, SAN, Facultad de Medicina (UNL) Use of Immunotherapy in Patients With Organ Transplants SpeakerNaoka Murakami nmurakami1@bwh.harvard.eduUnited StatesBrigham and Women\'s Hospital, Harvard Medical S Transplantation Outcomes in Recipients with History of Cancer SpeakerGermaine Wong AustraliaUniversity of Sydney Novel Strategies for Enhanced Organ Preservation during Machine Perfusion SpeakerTobias Huber GermanyUniversity Medical Center Hamburg-Eppendorf Q and A Hall E
3:50 p.m. 5:40 p.m.	Professor Donal O'Donoghue Global Kidney Policy Forum: Advancing Accessibility in Kidney Health - Towards Sustainable Solutions PF2 ChairpersonIfeoma Ulasi NigeriaCollege of Medicine, University of Nigeria ModeratorNelson Alberto Castro trischt19@gmail.comArgentina Accessibility to CKD Diagnosis: Focus on CKDu (Chronic Kidney Disease of Unknown Origin) and Advancements in Diagnostic Approaches SpeakerRamon Garcia Trabanino rgtrab@gmail.comEl SalvadorSLANH Latin American Dialysis and Renal Transplantation Registry: Updates and Progress SpeakerMaria Gonzalez registro@slanh.netUruguaySLANH Special Situations in Argentina: Addressing the Challenges Faced by Individuals on Dialysis Without a Diagnosis in the Argentinian Registry SpeakerGuillermo Rosa Diez guillermo.rosadiez@hospitalitaliano.org.arArgentinaHospital Italiano de Buenos Aires; Argentinean Society of Nephrology; Latinoamerican Society of Nephrology and Hypertension; International Society of Nephrology Cardiovascular and Renal Risk Factors in Argentinian First Nations: A Study of Qom and Wichi Indigenous Groups SpeakerMaria Eugenia Victoria Bianchi bianchimaria@me.comArgentinaISN. SAN. Accessibility to Substitution Treatment in Latin America SpeakerAlejandro Ferreiro-Fuentes UruguayCentro de Nefrología. Universidad de la República, Accessibility to Programs of Prevention, and Early Detection and Treatment of Kidney Disease in Latin America SpeakerAlfonso Martin Cueto Manzano a_cueto_manzano@hotmail.comMexicoUnidad de Investigación Médica en Enfermedades Ren Break Panel Discussion and Closing Remarks by Valerie Luyckx, University of Zurich, Switzerland Hall C2
4:30 p.m. 5:30 p.m.	Designing Smart Clinical Trials SK05 ChairpersonDebbie Gipson debbie.gipson@nih.govUnited StatesNational Institutes of Health/NIDDK ChairpersonJonathan Barratt United KingdomUniversity of Leicester, Leicester, UK Patients Subphenotyping: The Example of Diabetic Kidney Disease SpeakerJohn Cijiang He cijiang.he@mssm.eduUnited StatesIcahn School of Medicine at Mount Sinai Power of AI to Develop Data-driven Early Detection, Diagnosis, and Management of Kidney Disease SpeakerLaura Mariani lmariani@umich.eduUnited StatesUniversity of Michigan Targeted Approaches in Clinical Trial Design SpeakerHiddo Lambers Heerspink H.J.Lambers.Heerspink@umcg.nlNetherlands Q and A Hall D

Day 3 - Tuesday April 16, 2024

Time	Session

9 a.m. 10:30 a.m.	Hi Aldo, What's New? Advances in Aldosterone in Health and Disease IK04 ChairpersonCarlos Schreck carlos.schreck@gmail.comArgentinaHospital Italiano de Buenos Aires- Nephrology ChairpersonKelly Haughton kidneydoctorpanama@gmail.comPanamaSLANH, Panama Why Are Fewer Than I% Of Hypertensive Patients Ever Screened For Primary Aldosteronism? SpeakerJohn Funder John.Funder@hudson.org.auAustraliaThe Hudson Institute of Medical Research Clayton 3168 Victoria Australia; Monash University, Clayton 3600 Victoria Australia Aldosterone and Disease SpeakerJordana Cohen jco@pennmedicine.upenn.eduUnited StatesUniversity of Pennsylvania New Trials Using Aldosterone Synthese Blockade SpeakerMichel Azizi michel.azizi@aphp.frFranceUniversité Paris Cité, Hypertension department, Hô Targeting MR for Heart and Kidney Protection SpeakerHiddo Lambers Heerspink H.J.Lambers.Heerspink@umcg.nlNetherlands Q and A Hall E
9 a.m. 10:30 a.m.	Clinical Management of Glomerulonephritis (GN) SK06 ChairpersonJuan Manuel Mejia Vilet jmmejia@hotmail.comMexicoInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán ChairpersonValeria Alberton vgalberton@gmail.comArgentinaHospital Fernandez/ Hospital El Cruce Updates on IgAN Management SpeakerHernán Trimarchi ArgentinaHOSPITAL BRITÁNICO DE BUENOS AIRES Membranous GN Classification and Management SpeakerPierre Ronco FranceHôpital Tenon MPGN Updates SpeakerSanjeev Sethi United StatesMayo Clinic Managing Vasculitis SpeakerRoberta Fenoglio roberta.fenoglio@unito.itItalyOspedale San Giovanni Bosco Q and A Hall A
11 a.m. 12:15 p.m.	Plenary Session 4: Insights into SGLT2 Inhibitors: A Story of Discovery (Ele Ferrannini, Italy) PL4 ChairpersonAlessia Fornoni United StatesUniversity of Miami ChairpersonLiz Lightstone United KingdomImperial College London ChairpersonMasaomi Nangaku Japan Acceptance Speech: Bywaters Award SpeakerMotoko Yanagita JapanKyoto University Insights into SGLT2 Inhibitors: A Story of Discovery. Donald Seldin Lecture SpeakerEle Ferrannini eleferrannini@gmail.comItalyUniversity of Pisa ELP2 Graduation SpeakerMasaomi Nangaku Japan Hall A
12:30 p.m. 1:30 p.m.	Hot Debate in CKD Hypertension Management: Targeting Systolic BP Below 120? IK05 ChairpersonMarcelo Orías marcelo.orias@gmail.comArgentina ChairpersonMark Sarnak msarnak@tuftsmedicalcenter.orgUnited StatesTufts Medical Center Hot Debate in CKD Hypertension Management: Targeting Systolic BP Below 120? - PROS SpeakerTara Chang tichang@stanford.eduUnited StatesStanford University Hot Debate in CKD Hypertension Management: Targeting Systolic BP Below 120? - CONS SpeakerJordana Cohen jco@pennmedicine.upenn.eduUnited StatesUniversity of Pennsylvania Hall A